Medical Search

Medical News from WebMD

New Warnings for MS Drug Gilenya After FDA Review

April 20, 2012, 7:18 am by WebMD

Novartis, the maker of the drug Gilenya (fingolimod), a once-daily oral capsule taken for multiple sclerosis, has added stronger warnings to labels and prescription information about the drug’s possible heart risks, according to a company statement.

Featured Medical Stories

Newest Fitbits

Have you seen the NEW FITBIT??

Fitbit is now a health tracker and fasion statement. See all the new beautiful models here >> See the HOTTEST new Fitbits!

See the HOT Fitbit Blaze Now Compare All Fitbit Products Google Fitbit
Sense Sleep Tracker

Awaken Your Sleeping Beauty With This Sleep Tracker

Sleep is the new hot topic and from what science tells us, it is the holy grail of health. If you can track it, you can optimize it. If you can optimize it, you can benefit from it. This hot new sleep tracker by Hello is the perfect sleep tracker for the perfect price. There is beauty in health, and it needs to be awakened. But before that, let's get the best sleep of our lives. Learn more here: Sense Sleep Tracker on Amazon

Sleep Tracker on Amazon Sleep Tracker Reviews Google Sleep Trackers

More medical news from WebMD

1 in 3 Young Athletes With Concussion Returns to Play on Same Day
WebMD : October 21, 2016, 7:15 am
But, medical recommendation is to stay out of game after head injury

Be Aware of What You Share Online About Your Kids
WebMD : October 21, 2016, 7:15 am
New review offers parents advice on how to be more careful with postings that could affect their children

Pediatricians: Kids Need 'Media Use Plan' From Parents
WebMD : October 21, 2016, 7:15 am
Suggestions include no screen time for those under 18 months, not using media as 'soothing tool'

CDC Sets Florida Testing Zone for Pregnant Women
WebMD : October 20, 2016, 11:15 am
Latest recommendation covers more than the two areas in Miami-Dade where local transmission is occurring

Monitoring, Not Treatment, May Be Better for Some Prostate Cancer Patients
WebMD : October 20, 2016, 11:15 am
In Sweden, 90 percent with very low risk disease choose this option instead of immediate treatment, researchers report